CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,593,000 | +173.3% | 420,500 | +83.8% | 0.33% | +135.7% |
| Q3 2015 | $2,412,000 | -66.9% | 228,800 | -20.7% | 0.14% | -64.5% |
| Q2 2015 | $7,281,000 | -9.5% | 288,700 | 0.0% | 0.39% | -34.9% |
| Q1 2015 | $8,046,000 | +52.7% | 288,700 | 0.0% | 0.60% | +5.2% |
| Q4 2014 | $5,269,000 | +40.8% | 288,700 | 0.0% | 0.58% | +10.2% |
| Q3 2014 | $3,742,000 | -20.6% | 288,700 | 0.0% | 0.52% | -18.6% |
| Q2 2014 | $4,712,000 | -7.6% | 288,700 | 0.0% | 0.64% | -19.1% |
| Q1 2014 | $5,101,000 | -18.0% | 288,700 | +12.3% | 0.79% | -58.7% |
| Q4 2013 | $6,222,000 | – | 257,000 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |